Synergistic effect of K-18 and concomitant hyperthermia for treatment of Lewis lung carcinoma in mice
- PMID: 2409315
- DOI: 10.1007/BF02469749
Synergistic effect of K-18 and concomitant hyperthermia for treatment of Lewis lung carcinoma in mice
Abstract
We investigated the synergistic anti-tumor effects of K-18 (conjugate of human gamma-globulin and melphalan) and concomitantly administered hyperthermia on Lewis lung carcinoma in mice. The antitumor effect of a subeffective dose of K-18 or an equivalent dose of melphalan alone was enhanced by local hyperthermia. K-18 administration demonstrated a greater potentiation for inhibition of tumor growth than that of melphalan alone. Local hyperthermia plus K-18 reduced the dose of melphalan required for tumor growth inhibition by melphalan alone. The combined application of K-18 and hyperthermia for treating cancer warrants further study.
Similar articles
-
[A study of the antineoplastic activity of K18].Gan To Kagaku Ryoho. 1986 May;13(5):1985-91. Gan To Kagaku Ryoho. 1986. PMID: 2423038 Japanese.
-
Antitumor effect of K18 on metastatic models.In Vivo. 1988 Nov-Dec;2(6):389-92. In Vivo. 1988. PMID: 2485138
-
[Clinical phase II study of K-18 in cancer of the digestive organs].Gan To Kagaku Ryoho. 1988 Feb;15(2):361-4. Gan To Kagaku Ryoho. 1988. PMID: 2449136 Japanese. No abstract available.
-
Rationale for different approaches to combined melphalan and hyperthermia in regional isolated perfusion.Eur J Cancer. 1997 Sep;33(10):1546-50. doi: 10.1016/s0959-8049(97)00116-0. Eur J Cancer. 1997. PMID: 9389913 Review.
-
Rationale and clinical status of 41.8 degrees C systemic hyperthermia tumor necrosis factor, and melphalan for neoplastic disease.Anticancer Res. 1997 Jul-Aug;17(4B):2891-4. Anticancer Res. 1997. PMID: 9329556 Review.
References
MeSH terms
Substances
LinkOut - more resources
Medical